Literature DB >> 17163343

A minimally invasive transsulcal approach to the paracentral inner lesion.

N Mikuni1, N Hashimoto.   

Abstract

OBJECTIVE: Surgical options to remove lesions located deep in the sulcus at the paracentral area are limited. To minimize therapeutic morbidities, such as cortical injuries before the removal, a transsulcal approach was applied by taking the results of neuroimaging and functional mapping into consideration.
METHODS: Four patients with paracentral inner lesions including anaplastic astrocytoma, cortical dysplasia, and cavernous angioma were operated on. All lesions were located deep in the paracentral sulci. According to the outcome of MRI and functional mapping of the cortex over the lesion, the central or the postcentral sulcus was opened toward the lesion. Immediately after complete dissection of the sulcus to remove the lesion, neurological findings were evaluated in the awake state.
RESULTS: All lesions were situated beneath the hand or foot area. The transsulcal approach was successfully conducted without any neurological deficits in all cases.
CONCLUSION: Microsurgical techniques based on anatomic and functional information allow surgeons to reach the lesions deep in the paracentral area safely.

Entities:  

Mesh:

Year:  2006        PMID: 17163343     DOI: 10.1055/s-2006-955070

Source DB:  PubMed          Journal:  Minim Invasive Neurosurg        ISSN: 0946-7211


  2 in total

1.  Mapping the superficial morphology of the occipital lobe: proposal of a universal nomenclature for clinical and anatomical use.

Authors:  Christos Koutsarnakis; Spyridon Komaitis; Evangelos Drosos; Aristotelis V Kalyvas; Georgios P Skandalakis; Faidon Liakos; Eleftherios Neromyliotis; Evgenia Lani; Theodosis Kalamatianos; George Stranjalis
Journal:  Neurosurg Rev       Date:  2019-11-22       Impact factor: 3.042

Review 2.  Rethinking the standard trans-cortical approaches in the light of superficial white matter anatomy.

Authors:  Francesco Latini; Mats Ryttlefors
Journal:  Neural Regen Res       Date:  2015-12       Impact factor: 5.135

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.